Monday, 28 October 2013

JAMA study questions FDA's shorter drug approval times

By Toni Clarke WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday...


found it for you found it I found it found here

No comments:

Post a Comment

Note: only a member of this blog may post a comment.